🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Chen‐Yi Cheung

University of Otago

ORCID: 0000-0002-5850-0919
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Whole genome CRISPRi screening identifies druggable vulnerabilities in an isoniazid resistant strain of Mycobacterium tuberculosis”.

Whole genome CRISPRi screening identifies druggable vulnerabilities in an isoniazid resistant strain of Mycobacterium tuberculosis

Nature Communications(2024)10.1038/s41467-024-54072-w
N/A
0.595DataRank · unranked
23 citations

William J Jowsey, Chen‐Yi Cheung, C. Smart, Hannah Klaus, Noon E. J. Seeto +13 more

M. tuberculosis relies on trace oxygen to maintain energy homeostasis and survive in hypoxic environments

Cell Reports(2023)10.1016/j.celrep.2023.112444
N/A
0DataRank · unranked
49 citations

Samsher Singh, Kiel Hards, Chen‐Yi Cheung, Ekaterina Sviriaeva, Amir Banaei‐Esfahani +4 more

Verapamil and its metabolite norverapamil inhibit the Mycobacterium tuberculosis MmpS5L5 efflux pump to increase bedaquiline activity

Proceedings of the National Academy of Sciences(2025)10.1073/pnas.2426827122
N/A
0DataRank · unranked
17 citations

Natalie J.E. Waller, Chen‐Yi Cheung, William J Jowsey, Michael T Chrisp, Mark Troll +5 more

Verapamil and its metabolite norverapamil inhibit the Mycobacterium tuberculosis MmpS5L5 efflux pump to potentiate the activity bedaquiline and other antitubercular drugs

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.02.06.636695
N/A
0DataRank · unranked
0 citations

Natalie J.E. Waller, Chen‐Yi Cheung, William J Jowsey, Michael T Chrisp, Mark Troll +5 more